Internal Medicine, Medical Oncology · Houston, TX
NPI
1912053596
Since 2007
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1515 Holcombe Blvd
Houston, TX, 77030
Phone (713) 792-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$60K
752 services
Medicare patients, 2024
315
Average age 74
Drug cost, 2024
$2.2M
348 prescriptions
Company payments, 2025
$2,308
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rodabe Amaria was code 99214 (office e&m - established), 369 times for 204 patients. In total Rodabe Amaria billed 752 services in 16 codes, and Medicare paid $60K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-01-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 369 | 204 | $69.64 | $26K |
| 99233 Hospital E&M - Subsequent | Facility | 109 | 30 | $93.37 | $10K |
| 99213 Office E&M - Established | Facility | 59 | 41 | $52.58 | $3,102 |
| 99205 Office E&M - New | Facility | 50 | 50 | $139.18 | $6,959 |
| 99215 Office E&M - Established | Facility | 45 | 31 | $109.80 | $4,941 |
| 99239 Hospital Discharge Management | Facility | 22 | 20 | $85.93 | $1,891 |
| 99214 Office E&M - Established | Office | 17 | 12 | $93.67 | $1,592 |
| 99441 Telephone Services | Office | 14 | 13 | $42.71 | $598 |
By year: 2022 $56K for 699 services; 2023 $52K for 649 services; 2024 $60K for 752 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rodabe Amaria prescribed most often to Medicare patients was Mektovi (Binimetinib), with 70 prescriptions and refills. In total Rodabe Amaria wrote 348 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mektovi Binimetinib | 70 | 70 | Under 11 | $921K |
| Braftovi Encorafenib | 69 | 69 | Under 11 | $1.0M |
| Prednisone Generic | 27 | 29 | 17 | $150 |
| Hydrocortisone Generic | 13 | 14 | Under 11 | $460 |
| Eliquis Apixaban | 12 | 12 | Under 11 | $5,211 |
| Levothyroxine Sodium Generic | 12 | 20 | Under 11 | $115 |
| Tafinlar Dabrafenib Mesylate | 11 | 11 | Under 11 | $164K |
Brand drugs: 183 claims; generic drugs: 165 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rodabe Amaria $2,308 ($85.45 in general payments such as food, travel and fees and $2,222 for research) from 5 companies. The largest payer was F. Hoffmann-La Roche AG with $1,272.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.